19 /100
LOW RISK
Score updated May 29, 2026

MLTX — MoonLake Immunotherapeutics Dilution Risk Tracker

Track MLTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MLTX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for MLTX.
🔔 Track MLTX — Get forecast alerts →

💹 Market Data

Market Cap$1.38B
Shares Outstanding73.62M
Float38.25M
Cash$393.97M
Debt$75.71M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 38.8% shares (2025Q4 vs prior)
134 institutional holders · 60.26M shares
#1 BVF INC/IL 19.75M shares
#2 Deep Track Capital, LP 4.61M shares
#3 Cormorant Asset Management, LP 4.36M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest6.32M
Days to Cover9.2
% of Float15.8%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track MLTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MLTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for MLTX
📊 MLTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MLTX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.